Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial
Authors
Keywords
-
Journal
Trials
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-06
DOI
10.1186/s13063-019-3989-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
- (2017) Jicheng Lv et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
- (2017) Hernán Trimarchi et al. KIDNEY INTERNATIONAL
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
- (2017) Bengt C Fellström et al. LANCET
- Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis
- (2017) Yu-Huan Song et al. BMC Nephrology
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
- (2016) Richard A. Lafayette et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Recent Advances in Traditional Chinese Medicine for Kidney Disease
- (2015) Yifei Zhong et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study
- (2015) V. Tesar et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- (2015) Thomas Rauen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunoglobulin A nephropathy: current progress and future directions
- (2015) Chunlei Zhang et al. Translational Research
- Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial
- (2014) Li Zhang et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Evaluation of the Oxford Classification of IgA Nephropathy: A Systematic Review and Meta-analysis
- (2013) Jicheng Lv et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- IgA Nephropathy
- (2013) Robert J. Wyatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
- (2013) A.-W. Chan et al. BMJ-British Medical Journal
- Clinical Features and Outcomes of IgA Nephropathy with Nephrotic Syndrome
- (2012) J.-K. Kim et al. Clinical Journal of the American Society of Nephrology
- Chapter 10: Immunoglobulin A nephropathy
- (2012) Kidney International Supplements
- Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: A multicenter double-blinded randomized controlled trial
- (2011) Yong-jun Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population
- (2011) W. Le et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Long-term study of mycophenolate mofetil treatment in IgA nephropathy
- (2009) Sydney C.W. Tang et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search